Probiotics and necrotizing enterocolitis in preterm infants after the food and drug administration warning actions

Veeral N Tolia1,2, Monica M Bennett3, Darren Handler4

  • 1Pediatrix Center for Research Education, Quality and Safety, Sunrise, FL, USA. veeraltolia@gmail.com.

Insights

Following FDA actions, probiotic use in preterm infants dropped significantly, leading to an increase in necrotizing enterocolitis (NEC) in high-use centers. Low-use centers saw no change in NEC rates.

Area of Science:

  • Neonatalogy
  • Gastroenterology
  • Public Health

Background:

  • Necrotizing enterocolitis (NEC) is a serious gastrointestinal condition affecting preterm infants.
  • Probiotics are often used to prevent NEC in vulnerable neonates.
  • FDA actions in 2023 prompted changes in clinical practice regarding probiotic use.

Purpose of the Study:

  • To assess the impact of FDA actions on probiotic use in preterm infants.
  • To evaluate the subsequent changes in necrotizing enterocolitis (NEC) incidence.
  • To compare NEC rates between high and low probiotic-use centers post-FDA action.

Main Methods:

  • Natural experiment observational study utilizing the Pediatrix Clinical Data Warehouse.
  • Comparison of NEC incidence in high probiotic-use centers (HUCs) versus low-use centers (LUCs).
  • Difference-in-differences analysis applied to data from October 2022 to March 2025.

Main Results:

  • Probiotic use dramatically decreased in HUCs (86% to 6.9%) post-FDA action, with a smaller decrease in LUCs (13% to 0.1%).
  • NEC incidence rose in HUCs (2.7% to 4.4%) but remained stable at 3.6% in LUCs.
  • An adjusted increase in NEC was observed in HUCs compared to LUCs (1.18%; P=0.045).

Conclusions:

  • Rapid cessation of probiotic use in centers with routine use was associated with increased NEC incidence.
  • These findings highlight the potential impact of practice changes on neonatal outcomes.
  • Further research is needed to understand the long-term implications and optimal strategies for NEC prevention.
Abstract

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...